nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—Valproic Acid—migraine	0.0547	0.0731	CbGbCtD
Zafirlukast—ABCG2—Verapamil—migraine	0.0516	0.0689	CbGbCtD
Zafirlukast—CYP2E1—Amitriptyline—migraine	0.0463	0.0619	CbGbCtD
Zafirlukast—CYP2C19—Timolol—migraine	0.0377	0.0504	CbGbCtD
Zafirlukast—CYP2C8—Amitriptyline—migraine	0.0346	0.0463	CbGbCtD
Zafirlukast—CYP2C19—Propranolol—migraine	0.0336	0.0449	CbGbCtD
Zafirlukast—CYP2C8—Valproic Acid—migraine	0.0316	0.0422	CbGbCtD
Zafirlukast—CYP1A2—Propranolol—migraine	0.031	0.0414	CbGbCtD
Zafirlukast—CYP2C19—Amitriptyline—migraine	0.029	0.0388	CbGbCtD
Zafirlukast—CYP2D6—Timolol—migraine	0.0286	0.0383	CbGbCtD
Zafirlukast—CYP2C8—Verapamil—migraine	0.0275	0.0367	CbGbCtD
Zafirlukast—CYP1A2—Amitriptyline—migraine	0.0268	0.0358	CbGbCtD
Zafirlukast—CYP2C19—Valproic Acid—migraine	0.0265	0.0354	CbGbCtD
Zafirlukast—CYP2D6—Propranolol—migraine	0.0255	0.0341	CbGbCtD
Zafirlukast—CYP1A2—Valproic Acid—migraine	0.0244	0.0327	CbGbCtD
Zafirlukast—CYP2C9—Amitriptyline—migraine	0.0241	0.0323	CbGbCtD
Zafirlukast—CYP2C19—Topiramate—migraine	0.0239	0.0319	CbGbCtD
Zafirlukast—CYP2C19—Verapamil—migraine	0.023	0.0308	CbGbCtD
Zafirlukast—CYP2D6—Amitriptyline—migraine	0.0221	0.0295	CbGbCtD
Zafirlukast—CYP2C9—Valproic Acid—migraine	0.022	0.0294	CbGbCtD
Zafirlukast—CYP1A2—Verapamil—migraine	0.0213	0.0284	CbGbCtD
Zafirlukast—CYP2C9—Verapamil—migraine	0.0192	0.0256	CbGbCtD
Zafirlukast—CYP2D6—Verapamil—migraine	0.0175	0.0234	CbGbCtD
Zafirlukast—CYP3A4—Propranolol—migraine	0.0162	0.0217	CbGbCtD
Zafirlukast—CYP3A4—Amitriptyline—migraine	0.014	0.0188	CbGbCtD
Zafirlukast—CYP3A4—Valproic Acid—migraine	0.0128	0.0171	CbGbCtD
Zafirlukast—CYP3A4—Topiramate—migraine	0.0115	0.0154	CbGbCtD
Zafirlukast—CYP3A4—Verapamil—migraine	0.0111	0.0149	CbGbCtD
Zafirlukast—CYSLTR2—Endothelins—EDNRA—migraine	0.00179	0.0252	CbGpPWpGaD
Zafirlukast—Eosinophilia—Amitriptyline—migraine	0.00138	0.00765	CcSEcCtD
Zafirlukast—Blister—Gabapentin—migraine	0.00136	0.00753	CcSEcCtD
Zafirlukast—Contusion—Valproic Acid—migraine	0.00136	0.0075	CcSEcCtD
Zafirlukast—Accidental injury—Valproic Acid—migraine	0.00134	0.00739	CcSEcCtD
Zafirlukast—Haemoptysis—Gabapentin—migraine	0.00132	0.00733	CcSEcCtD
Zafirlukast—Injury—Verapamil—migraine	0.00132	0.00729	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HTR2B—migraine	0.00127	0.0179	CbGpPWpGaD
Zafirlukast—Upset stomach—Topiramate—migraine	0.00126	0.00696	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—EDNRA—migraine	0.00124	0.0175	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Amitriptyline—migraine	0.00122	0.00676	CcSEcCtD
Zafirlukast—Jaundice—Amitriptyline—migraine	0.00121	0.00672	CcSEcCtD
Zafirlukast—Vasculitis—Valproic Acid—migraine	0.00121	0.0067	CcSEcCtD
Zafirlukast—Agranulocytosis—Amitriptyline—migraine	0.00116	0.00643	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Timolol—migraine	0.00116	0.00641	CcSEcCtD
Zafirlukast—Influenza like illness—Valproic Acid—migraine	0.00115	0.00635	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00114	0.016	CbGpPWpGaD
Zafirlukast—Contusion—Gabapentin—migraine	0.00112	0.00622	CcSEcCtD
Zafirlukast—Hepatitis—Amitriptyline—migraine	0.00112	0.00619	CcSEcCtD
Zafirlukast—Hypoaesthesia—Amitriptyline—migraine	0.00111	0.00616	CcSEcCtD
Zafirlukast—Accidental injury—Gabapentin—migraine	0.00111	0.00613	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Gabapentin—migraine	0.00109	0.00601	CcSEcCtD
Zafirlukast—Neutropenia—Propranolol—migraine	0.00106	0.00589	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00106	0.0149	CbGpPWpGaD
Zafirlukast—Abdominal discomfort—Verapamil—migraine	0.001	0.00555	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000986	0.0138	CbGpPWpGaD
Zafirlukast—Hepatic function abnormal—Valproic Acid—migraine	0.000982	0.00543	CcSEcCtD
Zafirlukast—Swelling—Valproic Acid—migraine	0.000973	0.00538	CcSEcCtD
Zafirlukast—Hepatic failure—Valproic Acid—migraine	0.000955	0.00528	CcSEcCtD
Zafirlukast—Sensory loss—Topiramate—migraine	0.000952	0.00527	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CALCRL—migraine	0.000952	0.0134	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—RAMP1—migraine	0.000952	0.0134	CbGpPWpGaD
Zafirlukast—Agranulocytosis—Propranolol—migraine	0.000947	0.00524	CcSEcCtD
Zafirlukast—Injury—Valproic Acid—migraine	0.000934	0.00517	CcSEcCtD
Zafirlukast—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—migraine	0.000933	0.0131	CbGpPWpGaD
Zafirlukast—Neuropathy—Gabapentin—migraine	0.00092	0.00509	CcSEcCtD
Zafirlukast—Jaundice—Verapamil—migraine	0.000909	0.00503	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000908	0.0127	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—FOS—migraine	0.000905	0.0127	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Amitriptyline—migraine	0.000903	0.005	CcSEcCtD
Zafirlukast—Dermatitis bullous—Valproic Acid—migraine	0.000898	0.00497	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HTR2B—migraine	0.000884	0.0124	CbGpPWpGaD
Zafirlukast—Malaise—Amitriptyline—migraine	0.000878	0.00486	CcSEcCtD
Zafirlukast—Sinusitis—Verapamil—migraine	0.000875	0.00484	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000844	0.0118	CbGpPWpGaD
Zafirlukast—Hepatitis—Verapamil—migraine	0.000838	0.00463	CcSEcCtD
Zafirlukast—Hypoaesthesia—Verapamil—migraine	0.000833	0.00461	CcSEcCtD
Zafirlukast—Discomfort—Amitriptyline—migraine	0.000819	0.00453	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Gabapentin—migraine	0.000814	0.00451	CcSEcCtD
Zafirlukast—Swelling—Gabapentin—migraine	0.000807	0.00446	CcSEcCtD
Zafirlukast—Influenza like illness—Topiramate—migraine	0.000801	0.00443	CcSEcCtD
Zafirlukast—Oedema—Amitriptyline—migraine	0.000795	0.0044	CcSEcCtD
Zafirlukast—Hepatic failure—Gabapentin—migraine	0.000792	0.00438	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00079	0.0111	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—NPS—migraine	0.000788	0.0111	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TAC1—migraine	0.000788	0.0111	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Amitriptyline—migraine	0.000778	0.0043	CcSEcCtD
Zafirlukast—Neuropathy—Topiramate—migraine	0.000774	0.00428	CcSEcCtD
Zafirlukast—Injury—Gabapentin—migraine	0.000774	0.00428	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HTR2C—migraine	0.000772	0.0108	CbGpPWpGaD
Zafirlukast—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.000757	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—EDNRA—migraine	0.000751	0.0105	CbGpPWpGaD
Zafirlukast—Dermatitis bullous—Gabapentin—migraine	0.000745	0.00412	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000735	0.0103	CbGpPWpGaD
Zafirlukast—Eosinophilia—Valproic Acid—migraine	0.000735	0.00406	CcSEcCtD
Zafirlukast—Insomnia—Amitriptyline—migraine	0.000719	0.00398	CcSEcCtD
Zafirlukast—Abdominal discomfort—Valproic Acid—migraine	0.000711	0.00394	CcSEcCtD
Zafirlukast—Liver function test abnormal—Timolol—migraine	0.000706	0.0039	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000704	0.00988	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000704	0.00988	CbGpPWpGaD
Zafirlukast—Dyspepsia—Amitriptyline—migraine	0.000699	0.00387	CcSEcCtD
Zafirlukast—Neutropenia—Valproic Acid—migraine	0.000694	0.00384	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR1D—migraine	0.000692	0.0097	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000691	0.00969	CbGpPWpGaD
Zafirlukast—Fatigue—Amitriptyline—migraine	0.000685	0.00379	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000683	0.00959	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000672	0.00943	CbGpPWpGaD
Zafirlukast—Angioedema—Verapamil—migraine	0.000666	0.00369	CcSEcCtD
Zafirlukast—Hepatic failure—Topiramate—migraine	0.000666	0.00369	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—RAMP1—migraine	0.00066	0.00926	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CALCRL—migraine	0.00066	0.00926	CbGpPWpGaD
Zafirlukast—Liver function test abnormal—Gabapentin—migraine	0.000657	0.00364	CcSEcCtD
Zafirlukast—Feeling abnormal—Amitriptyline—migraine	0.000655	0.00362	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR2B—migraine	0.000643	0.00902	CbGpPWpGaD
Zafirlukast—Infection—Propranolol—migraine	0.000643	0.00356	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000642	0.00901	CbGpPWpGaD
Zafirlukast—Urticaria—Amitriptyline—migraine	0.000631	0.00349	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00063	0.00883	CbGpPWpGaD
Zafirlukast—Body temperature increased—Amitriptyline—migraine	0.000628	0.00347	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—FOS—migraine	0.000627	0.0088	CbGpPWpGaD
Zafirlukast—Myalgia—Verapamil—migraine	0.000621	0.00343	CcSEcCtD
Zafirlukast—Arthralgia—Verapamil—migraine	0.000621	0.00343	CcSEcCtD
Zafirlukast—Sinusitis—Valproic Acid—migraine	0.000621	0.00343	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000618	0.00867	CbGpPWpGaD
Zafirlukast—Agranulocytosis—Valproic Acid—migraine	0.000617	0.00342	CcSEcCtD
Zafirlukast—Discomfort—Verapamil—migraine	0.000613	0.00339	CcSEcCtD
Zafirlukast—Eosinophilia—Gabapentin—migraine	0.000609	0.00337	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000597	0.00838	CbGpPWpGaD
Zafirlukast—Haemoglobin—Valproic Acid—migraine	0.000597	0.0033	CcSEcCtD
Zafirlukast—Oedema—Verapamil—migraine	0.000595	0.00329	CcSEcCtD
Zafirlukast—Haemorrhage—Valproic Acid—migraine	0.000594	0.00329	CcSEcCtD
Zafirlukast—Infection—Verapamil—migraine	0.000591	0.00327	CcSEcCtD
Zafirlukast—Hypoaesthesia—Valproic Acid—migraine	0.000591	0.00327	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000585	0.00821	CbGpPWpGaD
Zafirlukast—Insomnia—Propranolol—migraine	0.000585	0.00324	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000581	0.00815	CbGpPWpGaD
Zafirlukast—Asthenia—Amitriptyline—migraine	0.00057	0.00315	CcSEcCtD
Zafirlukast—Dyspepsia—Propranolol—migraine	0.000569	0.00315	CcSEcCtD
Zafirlukast—Pruritus—Amitriptyline—migraine	0.000562	0.00311	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Propranolol—migraine	0.000559	0.00309	CcSEcCtD
Zafirlukast—Fatigue—Propranolol—migraine	0.000558	0.00309	CcSEcCtD
Zafirlukast—Pain—Propranolol—migraine	0.000553	0.00306	CcSEcCtD
Zafirlukast—Liver function test abnormal—Topiramate—migraine	0.000553	0.00306	CcSEcCtD
Zafirlukast—Sinusitis—Timolol—migraine	0.000553	0.00306	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00055	0.00772	CbGpPWpGaD
Zafirlukast—Agranulocytosis—Timolol—migraine	0.00055	0.00304	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—NPS—migraine	0.000546	0.00766	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TAC1—migraine	0.000546	0.00766	CbGpPWpGaD
Zafirlukast—Diarrhoea—Amitriptyline—migraine	0.000544	0.00301	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Verapamil—migraine	0.000542	0.003	CcSEcCtD
Zafirlukast—Insomnia—Verapamil—migraine	0.000538	0.00298	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CALCRL—migraine	0.000538	0.00755	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—RAMP1—migraine	0.000538	0.00755	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Gabapentin—migraine	0.000538	0.00297	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HTR2C—migraine	0.000535	0.00751	CbGpPWpGaD
Zafirlukast—Jaundice—Gabapentin—migraine	0.000535	0.00296	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00053	0.00743	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Propranolol—migraine	0.000529	0.00293	CcSEcCtD
Zafirlukast—Dizziness—Amitriptyline—migraine	0.000525	0.00291	CcSEcCtD
Zafirlukast—Dyspepsia—Verapamil—migraine	0.000524	0.0029	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000523	0.00734	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000522	0.00732	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000522	0.00732	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—EDNRA—migraine	0.000521	0.00731	CbGpPWpGaD
Zafirlukast—Sinusitis—Gabapentin—migraine	0.000515	0.00285	CcSEcCtD
Zafirlukast—Urticaria—Propranolol—migraine	0.000514	0.00284	CcSEcCtD
Zafirlukast—Fatigue—Verapamil—migraine	0.000513	0.00284	CcSEcCtD
Zafirlukast—Eosinophilia—Topiramate—migraine	0.000512	0.00283	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000512	0.00718	CbGpPWpGaD
Zafirlukast—Abdominal pain—Propranolol—migraine	0.000511	0.00283	CcSEcCtD
Zafirlukast—Body temperature increased—Propranolol—migraine	0.000511	0.00283	CcSEcCtD
Zafirlukast—Pain—Verapamil—migraine	0.000509	0.00282	CcSEcCtD
Zafirlukast—Vomiting—Amitriptyline—migraine	0.000505	0.00279	CcSEcCtD
Zafirlukast—Rash—Amitriptyline—migraine	0.000501	0.00277	CcSEcCtD
Zafirlukast—Dermatitis—Amitriptyline—migraine	0.0005	0.00277	CcSEcCtD
Zafirlukast—Back pain—Valproic Acid—migraine	0.0005	0.00277	CcSEcCtD
Zafirlukast—Headache—Amitriptyline—migraine	0.000498	0.00275	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000498	0.00698	CbGpPWpGaD
Zafirlukast—Abdominal discomfort—Topiramate—migraine	0.000496	0.00274	CcSEcCtD
Zafirlukast—Haemorrhage—Gabapentin—migraine	0.000492	0.00272	CcSEcCtD
Zafirlukast—Hepatitis—Gabapentin—migraine	0.000492	0.00272	CcSEcCtD
Zafirlukast—Feeling abnormal—Verapamil—migraine	0.00049	0.00271	CcSEcCtD
Zafirlukast—Hypoaesthesia—Gabapentin—migraine	0.00049	0.00271	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CALCRL—migraine	0.000488	0.00685	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—RAMP1—migraine	0.000488	0.00685	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000488	0.00685	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000488	0.00685	CbGpPWpGaD
Zafirlukast—Neutropenia—Topiramate—migraine	0.000484	0.00268	CcSEcCtD
Zafirlukast—Ill-defined disorder—Valproic Acid—migraine	0.00048	0.00265	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR1D—migraine	0.000479	0.00673	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000479	0.00672	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Propranolol—migraine	0.000477	0.00264	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HTR2A—migraine	0.000474	0.00665	CbGpPWpGaD
Zafirlukast—Urticaria—Verapamil—migraine	0.000473	0.00262	CcSEcCtD
Zafirlukast—Angioedema—Valproic Acid—migraine	0.000472	0.00261	CcSEcCtD
Zafirlukast—Nausea—Amitriptyline—migraine	0.000472	0.00261	CcSEcCtD
Zafirlukast—Malaise—Valproic Acid—migraine	0.000466	0.00258	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000466	0.00654	CbGpPWpGaD
Zafirlukast—Asthenia—Propranolol—migraine	0.000464	0.00257	CcSEcCtD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—MTHFR—migraine	0.00046	0.00645	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Topiramate—migraine	0.000452	0.0025	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000448	0.00629	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR2B—migraine	0.000446	0.00625	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000445	0.00625	CbGpPWpGaD
Zafirlukast—Diarrhoea—Propranolol—migraine	0.000443	0.00245	CcSEcCtD
Zafirlukast—Myalgia—Valproic Acid—migraine	0.00044	0.00244	CcSEcCtD
Zafirlukast—Arthralgia—Valproic Acid—migraine	0.00044	0.00244	CcSEcCtD
Zafirlukast—Hypersensitivity—Verapamil—migraine	0.000438	0.00243	CcSEcCtD
Zafirlukast—Discomfort—Valproic Acid—migraine	0.000435	0.00241	CcSEcCtD
Zafirlukast—Sinusitis—Topiramate—migraine	0.000433	0.00239	CcSEcCtD
Zafirlukast—Agranulocytosis—Topiramate—migraine	0.000431	0.00238	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000429	0.00601	CbGpPWpGaD
Zafirlukast—Dizziness—Propranolol—migraine	0.000428	0.00237	CcSEcCtD
Zafirlukast—Asthenia—Verapamil—migraine	0.000427	0.00236	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000424	0.00595	CbGpPWpGaD
Zafirlukast—Oedema—Valproic Acid—migraine	0.000422	0.00233	CcSEcCtD
Zafirlukast—Pruritus—Verapamil—migraine	0.000421	0.00233	CcSEcCtD
Zafirlukast—Angioedema—Timolol—migraine	0.000421	0.00233	CcSEcCtD
Zafirlukast—Infection—Valproic Acid—migraine	0.000419	0.00232	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR1B—migraine	0.000419	0.00588	CbGpPWpGaD
Zafirlukast—Haemoglobin—Topiramate—migraine	0.000416	0.0023	CcSEcCtD
Zafirlukast—Back pain—Gabapentin—migraine	0.000415	0.00229	CcSEcCtD
Zafirlukast—Haemorrhage—Topiramate—migraine	0.000414	0.00229	CcSEcCtD
Zafirlukast—Hepatitis—Topiramate—migraine	0.000414	0.00229	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000414	0.00581	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Valproic Acid—migraine	0.000413	0.00229	CcSEcCtD
Zafirlukast—Hypoaesthesia—Topiramate—migraine	0.000412	0.00228	CcSEcCtD
Zafirlukast—Vomiting—Propranolol—migraine	0.000411	0.00228	CcSEcCtD
Zafirlukast—Rash—Propranolol—migraine	0.000408	0.00226	CcSEcCtD
Zafirlukast—Dermatitis—Propranolol—migraine	0.000408	0.00225	CcSEcCtD
Zafirlukast—Diarrhoea—Verapamil—migraine	0.000407	0.00225	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR1A—migraine	0.000403	0.00566	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000403	0.00565	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Gabapentin—migraine	0.000398	0.0022	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—TAC1—migraine	0.000397	0.00557	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—NPS—migraine	0.000397	0.00557	CbGpPWpGaD
Zafirlukast—Dizziness—Verapamil—migraine	0.000394	0.00218	CcSEcCtD
Zafirlukast—Arthralgia—Timolol—migraine	0.000392	0.00217	CcSEcCtD
Zafirlukast—Myalgia—Timolol—migraine	0.000392	0.00217	CcSEcCtD
Zafirlukast—Angioedema—Gabapentin—migraine	0.000392	0.00217	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR1D—migraine	0.000391	0.00548	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR2C—migraine	0.00039	0.00547	CbGpPWpGaD
Zafirlukast—Discomfort—Timolol—migraine	0.000387	0.00214	CcSEcCtD
Zafirlukast—Malaise—Gabapentin—migraine	0.000386	0.00214	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Valproic Acid—migraine	0.000384	0.00213	CcSEcCtD
Zafirlukast—Nausea—Propranolol—migraine	0.000384	0.00213	CcSEcCtD
Zafirlukast—Insomnia—Valproic Acid—migraine	0.000382	0.00211	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000381	0.00535	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—EDNRA—migraine	0.000379	0.00532	CbGpPWpGaD
Zafirlukast—Vomiting—Verapamil—migraine	0.000378	0.00209	CcSEcCtD
Zafirlukast—Oedema—Timolol—migraine	0.000376	0.00208	CcSEcCtD
Zafirlukast—Rash—Verapamil—migraine	0.000375	0.00208	CcSEcCtD
Zafirlukast—Dermatitis—Verapamil—migraine	0.000375	0.00207	CcSEcCtD
Zafirlukast—Infection—Timolol—migraine	0.000373	0.00206	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CALCRL—migraine	0.000373	0.00523	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—RAMP1—migraine	0.000373	0.00523	CbGpPWpGaD
Zafirlukast—Headache—Verapamil—migraine	0.000373	0.00206	CcSEcCtD
Zafirlukast—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000371	0.00521	CbGpPWpGaD
Zafirlukast—Dyspepsia—Valproic Acid—migraine	0.000371	0.00205	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000367	0.00515	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000366	0.00514	CbGpPWpGaD
Zafirlukast—Myalgia—Gabapentin—migraine	0.000365	0.00202	CcSEcCtD
Zafirlukast—Arthralgia—Gabapentin—migraine	0.000365	0.00202	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CALCA—migraine	0.000365	0.00512	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Valproic Acid—migraine	0.000364	0.00202	CcSEcCtD
Zafirlukast—Fatigue—Valproic Acid—migraine	0.000364	0.00201	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR2B—migraine	0.000363	0.0051	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000362	0.00509	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000362	0.00507	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000362	0.00507	CbGpPWpGaD
Zafirlukast—Pain—Valproic Acid—migraine	0.000361	0.002	CcSEcCtD
Zafirlukast—Discomfort—Gabapentin—migraine	0.000361	0.00199	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR1D—migraine	0.000355	0.00498	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000355	0.00498	CbGpPWpGaD
Zafirlukast—Nausea—Verapamil—migraine	0.000353	0.00196	CcSEcCtD
Zafirlukast—Oedema—Gabapentin—migraine	0.00035	0.00194	CcSEcCtD
Zafirlukast—Back pain—Topiramate—migraine	0.000349	0.00193	CcSEcCtD
Zafirlukast—Feeling abnormal—Valproic Acid—migraine	0.000348	0.00192	CcSEcCtD
Zafirlukast—Infection—Gabapentin—migraine	0.000347	0.00192	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Valproic Acid—migraine	0.000345	0.00191	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000345	0.00484	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Gabapentin—migraine	0.000342	0.00189	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Timolol—migraine	0.000342	0.00189	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR7—migraine	0.000341	0.00479	CbGpPWpGaD
Zafirlukast—Insomnia—Timolol—migraine	0.00034	0.00188	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—RAMP1—migraine	0.000339	0.00475	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CALCRL—migraine	0.000339	0.00475	CbGpPWpGaD
Zafirlukast—Urticaria—Valproic Acid—migraine	0.000335	0.00185	CcSEcCtD
Zafirlukast—Ill-defined disorder—Topiramate—migraine	0.000335	0.00185	CcSEcCtD
Zafirlukast—Body temperature increased—Valproic Acid—migraine	0.000334	0.00185	CcSEcCtD
Zafirlukast—Abdominal pain—Valproic Acid—migraine	0.000334	0.00185	CcSEcCtD
Zafirlukast—Dyspepsia—Timolol—migraine	0.000331	0.00183	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR2B—migraine	0.00033	0.00463	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—migraine	0.000328	0.00461	CbGpPWpGaD
Zafirlukast—Malaise—Topiramate—migraine	0.000325	0.0018	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Timolol—migraine	0.000324	0.00179	CcSEcCtD
Zafirlukast—Fatigue—Timolol—migraine	0.000324	0.00179	CcSEcCtD
Zafirlukast—Pain—Timolol—migraine	0.000321	0.00178	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Gabapentin—migraine	0.000319	0.00176	CcSEcCtD
Zafirlukast—Insomnia—Gabapentin—migraine	0.000316	0.00175	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000314	0.0044	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Valproic Acid—migraine	0.000311	0.00172	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000311	0.00436	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Timolol—migraine	0.00031	0.00171	CcSEcCtD
Zafirlukast—Dyspepsia—Gabapentin—migraine	0.000308	0.0017	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Timolol—migraine	0.000307	0.0017	CcSEcCtD
Zafirlukast—Myalgia—Topiramate—migraine	0.000307	0.0017	CcSEcCtD
Zafirlukast—Arthralgia—Topiramate—migraine	0.000307	0.0017	CcSEcCtD
Zafirlukast—Discomfort—Topiramate—migraine	0.000303	0.00168	CcSEcCtD
Zafirlukast—Asthenia—Valproic Acid—migraine	0.000303	0.00167	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Gabapentin—migraine	0.000302	0.00167	CcSEcCtD
Zafirlukast—Fatigue—Gabapentin—migraine	0.000302	0.00167	CcSEcCtD
Zafirlukast—Pain—Gabapentin—migraine	0.000299	0.00165	CcSEcCtD
Zafirlukast—Pruritus—Valproic Acid—migraine	0.000299	0.00165	CcSEcCtD
Zafirlukast—Urticaria—Timolol—migraine	0.000298	0.00165	CcSEcCtD
Zafirlukast—Abdominal pain—Timolol—migraine	0.000297	0.00164	CcSEcCtD
Zafirlukast—Body temperature increased—Timolol—migraine	0.000297	0.00164	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.000296	0.00415	CbGpPWpGaD
Zafirlukast—Oedema—Topiramate—migraine	0.000294	0.00163	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000294	0.00412	CbGpPWpGaD
Zafirlukast—Infection—Topiramate—migraine	0.000292	0.00162	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR1B—migraine	0.00029	0.00408	CbGpPWpGaD
Zafirlukast—Diarrhoea—Valproic Acid—migraine	0.000289	0.0016	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—RAMP1—migraine	0.000289	0.00405	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CALCRL—migraine	0.000289	0.00405	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Gabapentin—migraine	0.000288	0.00159	CcSEcCtD
Zafirlukast—Thrombocytopenia—Topiramate—migraine	0.000288	0.00159	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Gabapentin—migraine	0.000286	0.00158	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR1A—migraine	0.00028	0.00392	CbGpPWpGaD
Zafirlukast—Dizziness—Valproic Acid—migraine	0.000279	0.00154	CcSEcCtD
Zafirlukast—Urticaria—Gabapentin—migraine	0.000278	0.00154	CcSEcCtD
Zafirlukast—Hypersensitivity—Timolol—migraine	0.000277	0.00153	CcSEcCtD
Zafirlukast—Body temperature increased—Gabapentin—migraine	0.000277	0.00153	CcSEcCtD
Zafirlukast—Abdominal pain—Gabapentin—migraine	0.000277	0.00153	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—NPS—migraine	0.000275	0.00386	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—TAC1—migraine	0.000275	0.00386	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR1D—migraine	0.000271	0.0038	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR2C—migraine	0.00027	0.00379	CbGpPWpGaD
Zafirlukast—Asthenia—Timolol—migraine	0.000269	0.00149	CcSEcCtD
Zafirlukast—Vomiting—Valproic Acid—migraine	0.000268	0.00148	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Topiramate—migraine	0.000268	0.00148	CcSEcCtD
Zafirlukast—Insomnia—Topiramate—migraine	0.000266	0.00147	CcSEcCtD
Zafirlukast—Rash—Valproic Acid—migraine	0.000266	0.00147	CcSEcCtD
Zafirlukast—Dermatitis—Valproic Acid—migraine	0.000266	0.00147	CcSEcCtD
Zafirlukast—Pruritus—Timolol—migraine	0.000266	0.00147	CcSEcCtD
Zafirlukast—Headache—Valproic Acid—migraine	0.000264	0.00146	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—EDNRA—migraine	0.000263	0.00369	CbGpPWpGaD
Zafirlukast—Dyspepsia—Topiramate—migraine	0.000259	0.00143	CcSEcCtD
Zafirlukast—Hypersensitivity—Gabapentin—migraine	0.000258	0.00143	CcSEcCtD
Zafirlukast—Diarrhoea—Timolol—migraine	0.000257	0.00142	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Topiramate—migraine	0.000254	0.00141	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000254	0.00356	CbGpPWpGaD
Zafirlukast—Fatigue—Topiramate—migraine	0.000254	0.0014	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CALCA—migraine	0.000253	0.00355	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2B—migraine	0.000252	0.00353	CbGpPWpGaD
Zafirlukast—Pain—Topiramate—migraine	0.000252	0.00139	CcSEcCtD
Zafirlukast—Asthenia—Gabapentin—migraine	0.000251	0.00139	CcSEcCtD
Zafirlukast—Nausea—Valproic Acid—migraine	0.000251	0.00139	CcSEcCtD
Zafirlukast—Dizziness—Timolol—migraine	0.000248	0.00137	CcSEcCtD
Zafirlukast—Pruritus—Gabapentin—migraine	0.000247	0.00137	CcSEcCtD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000247	0.00347	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR1D—migraine	0.000246	0.00345	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Topiramate—migraine	0.000242	0.00134	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Topiramate—migraine	0.000241	0.00133	CcSEcCtD
Zafirlukast—Diarrhoea—Gabapentin—migraine	0.000239	0.00132	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR2A—migraine	0.000239	0.00335	CbGpPWpGaD
Zafirlukast—Vomiting—Timolol—migraine	0.000239	0.00132	CcSEcCtD
Zafirlukast—Rash—Timolol—migraine	0.000237	0.00131	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR1B—migraine	0.000237	0.00332	CbGpPWpGaD
Zafirlukast—Dermatitis—Timolol—migraine	0.000237	0.00131	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR7—migraine	0.000236	0.00332	CbGpPWpGaD
Zafirlukast—Headache—Timolol—migraine	0.000235	0.0013	CcSEcCtD
Zafirlukast—Urticaria—Topiramate—migraine	0.000234	0.00129	CcSEcCtD
Zafirlukast—Body temperature increased—Topiramate—migraine	0.000233	0.00129	CcSEcCtD
Zafirlukast—Abdominal pain—Topiramate—migraine	0.000233	0.00129	CcSEcCtD
Zafirlukast—Dizziness—Gabapentin—migraine	0.000231	0.00128	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2B—migraine	0.000229	0.00321	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR1A—migraine	0.000228	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TAC1—migraine	0.000224	0.00315	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—NPS—migraine	0.000224	0.00315	CbGpPWpGaD
Zafirlukast—Nausea—Timolol—migraine	0.000223	0.00123	CcSEcCtD
Zafirlukast—Vomiting—Gabapentin—migraine	0.000222	0.00123	CcSEcCtD
Zafirlukast—Rash—Gabapentin—migraine	0.000221	0.00122	CcSEcCtD
Zafirlukast—Dermatitis—Gabapentin—migraine	0.00022	0.00122	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR2C—migraine	0.00022	0.00309	CbGpPWpGaD
Zafirlukast—Headache—Gabapentin—migraine	0.000219	0.00121	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000218	0.00305	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Topiramate—migraine	0.000217	0.0012	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR1B—migraine	0.000215	0.00302	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—EDNRA—migraine	0.000214	0.003	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000211	0.00297	CbGpPWpGaD
Zafirlukast—Asthenia—Topiramate—migraine	0.000211	0.00117	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR1D—migraine	0.00021	0.00294	CbGpPWpGaD
Zafirlukast—Pruritus—Topiramate—migraine	0.000208	0.00115	CcSEcCtD
Zafirlukast—Nausea—Gabapentin—migraine	0.000208	0.00115	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR1A—migraine	0.000207	0.0029	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CALCA—migraine	0.000206	0.00289	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NPS—migraine	0.000204	0.00286	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TAC1—migraine	0.000204	0.00286	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000201	0.00283	CbGpPWpGaD
Zafirlukast—Diarrhoea—Topiramate—migraine	0.000201	0.00111	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling Pathways—CALCRL—migraine	0.0002	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RAMP1—migraine	0.0002	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR2C—migraine	0.0002	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2B—migraine	0.000195	0.00274	CbGpPWpGaD
Zafirlukast—Dizziness—Topiramate—migraine	0.000195	0.00108	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—EDNRA—migraine	0.000194	0.00273	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR7—migraine	0.000193	0.00271	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000187	0.00263	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000187	0.00263	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CALCA—migraine	0.000187	0.00263	CbGpPWpGaD
Zafirlukast—Vomiting—Topiramate—migraine	0.000187	0.00104	CcSEcCtD
Zafirlukast—Rash—Topiramate—migraine	0.000186	0.00103	CcSEcCtD
Zafirlukast—Dermatitis—Topiramate—migraine	0.000185	0.00103	CcSEcCtD
Zafirlukast—Headache—Topiramate—migraine	0.000184	0.00102	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR7—migraine	0.000175	0.00246	CbGpPWpGaD
Zafirlukast—Nausea—Topiramate—migraine	0.000175	0.000967	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—LRP1—migraine	0.000172	0.00241	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR2A—migraine	0.000166	0.00232	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR1B—migraine	0.000164	0.0023	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	0.000159	0.00223	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR1A—migraine	0.000158	0.00222	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—NPS—migraine	0.000156	0.00218	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TAC1—migraine	0.000156	0.00218	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2C—migraine	0.000153	0.00214	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR1B—migraine	0.000149	0.00209	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—EDNRA—migraine	0.000148	0.00208	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR1D—migraine	0.000145	0.00204	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR1A—migraine	0.000143	0.00201	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CALCA—migraine	0.000143	0.002	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TAC1—migraine	0.000141	0.00198	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NPS—migraine	0.000141	0.00198	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2C—migraine	0.000139	0.00194	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000135	0.0019	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2B—migraine	0.000135	0.0019	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR2A—migraine	0.000135	0.00189	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EDNRA—migraine	0.000135	0.00189	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR7—migraine	0.000134	0.00188	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NOTCH4—migraine	0.000132	0.00185	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CALCA—migraine	0.00013	0.00182	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR1B—migraine	0.000127	0.00178	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR2A—migraine	0.000123	0.00172	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR1A—migraine	0.000122	0.00172	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR7—migraine	0.000121	0.0017	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TAC1—migraine	0.00012	0.00169	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NPS—migraine	0.00012	0.00169	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PGR—migraine	0.00012	0.00169	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—LRP1—migraine	0.000119	0.00167	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2C—migraine	0.000118	0.00166	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EDNRA—migraine	0.000115	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NOTCH3—migraine	0.000112	0.00157	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CALCA—migraine	0.000111	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR7—migraine	0.000103	0.00145	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2A—migraine	9.36e-05	0.00131	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NOTCH4—migraine	9.13e-05	0.00128	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFBR2—migraine	8.91e-05	0.00125	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR1B—migraine	8.81e-05	0.00124	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—migraine	8.68e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2A—migraine	8.5e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR1A—migraine	8.48e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PGR—migraine	8.35e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TAC1—migraine	8.35e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NPS—migraine	8.35e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2C—migraine	8.19e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EDNRA—migraine	7.96e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NOTCH3—migraine	7.76e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CALCA—migraine	7.67e-05	0.00108	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2A—migraine	7.24e-05	0.00102	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR7—migraine	7.17e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	6.55e-05	0.000919	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	6.55e-05	0.000919	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ESR1—migraine	6.43e-05	0.000902	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CACNA1A—migraine	6.34e-05	0.00089	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFBR2—migraine	6.17e-05	0.000866	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CACNA1A—migraine	6.09e-05	0.000855	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2A—migraine	5.02e-05	0.000705	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CACNA1A—migraine	4.55e-05	0.000639	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ESR1—migraine	4.46e-05	0.000625	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CACNA1A—migraine	3.94e-05	0.000552	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CACNA1A—migraine	3.51e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CACNA1A—migraine	3.23e-05	0.000453	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CACNA1A—migraine	3.2e-05	0.000449	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CACNA1A—migraine	2.74e-05	0.000384	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNA1A—migraine	2.11e-05	0.000296	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTHFR—migraine	2.1e-05	0.000294	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—migraine	2.02e-05	0.000283	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—migraine	1.51e-05	0.000211	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—migraine	1.3e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—migraine	1.16e-05	0.000163	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—migraine	1.07e-05	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—migraine	1.06e-05	0.000149	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—migraine	9.05e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—migraine	6.99e-06	9.8e-05	CbGpPWpGaD
